Reduction of circulating prostaglandin E2 level by antiserum against core lipopolysaccharide in a rabbit model of multiple organ failure

Journal of Trauma - Injury, Infection and Critical Care

Volumn 40, Issue 2, 1996, Pages 270-277

  Yao, Yong Ming ^a   Wang, Ya Ping ^a   Tian, Hui Min ^a   Yu, Yan ^a   Chang, Guo You ^a   Shi, Zhi Guo ^a   Sheng, Zhi Yong ^a  

^a 304TH HOSPITAL   (China)

Author keywords

Antiserum to lipopolysaccharide; Bacterial translocation; Endotoxemia; Hemorrhagic shock; Immunosuppression; Multiple organ failure; Prostaglandin E2

Indexed keywords

LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; HEMORRHAGIC SHOCK; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS; RABBIT; RESUSCITATION; SURVIVAL;

EID: 0030041796     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199602000-00017     Document Type: Article

References (41)

1. Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s: Systemic inflammatory response and organ dysfunction. JAMA 271:226, 1994
2. Abraham E: Host defense abnormalities after hemorrhage, trauma, and burns. Crit Care Med 17:934, 1989
3. Chaudry IH, Ayala A: Mechanism of increased susceptibility to infection following hemorrhage. Am J Surg 165(Suppl 2A):59S, 1993
4. 2)-dependent suppression of interleukin-2 (IL-2) production in patients with major trauma. J Trauma 27:837, 1987
5. 2 production in severely injured patients. Arch Surg 123:293, 1988
6. Eitel W, Morrison MH, Ayala A, et al: Blockade of prostaglandin production increase cachectin synthesis and prevents depression of macrophage functions after hemorrhagic shock. Ann Surg 213:265, 1991
7. 2. J Immunol 138:1074, 1987
8. 2 on the γ-interferon induction of antigen presenting ability in P388D1 cells and on IL-2 production by T-cell hybridomas. Cell Immunol 90:154, 1985
9. 2 depresses antigen-presenting cell function of peritoneal macrophages. J Surg Res 44:733, 1988
10. Knudsen PJ, Dinarello CA, Strom TB. Prostaglandins post-transcriptionally inhibit monocyte expression of interleukin-1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 137:3189, 1986
11. Borrta IL, Parnham MJ: Immunomodulatory-antiinflammatory functions of E-type prostaglandins: Minireview with emphasis on macrophage mediated effects. Int J Immunopharmacol 4:103, 1982
12. Ertel W, Morrison MH, Meldrum DR, et al: Ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage. J Surg Res 53:55, 1992
13. Faist E, Markewitz A, Fuchs D, et al: Immunomodulatory therapy with thymopentin and indomethacin: Successful restoration of interleukin-2 synthesis in patients undergoing major surgery. Ann Surg 214:264, 1991
14. Morrison DC, Ryan JL: Endotoxins and disease mechanisms. Annu Rev Med 38:417, 1987
15. Rush BF, Sori AJ, Murphy TP, et al: Endotoxemia and bacteremia during hemorrhagic shock: The link between trauma and sepsis? Ann Surg 207:549, 1988
16. Yao YM, Sheng ZY, Tian HM, et al: Gut-derived endotoxemia and multiple system organ failure following gunshot wounds combined with hemorrhagic shock: An experimental study in the dog. J Trauma 38:742, 1995
17. Deitch EA, Kemper AC, Specian RD, et al: A study of the relationship among survival, gut-origin sepsis, and bacterial translocation in a model of systemic inflammation. J Trauma 32:141, 1992
18. Yao YM, Bahrami S, Leichtfried G, et al: Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats: Effects of recombinant bactericidal/permeability-increasing protein. Ann Surg 211:398, 1995
19. Wardle EN: Cytokines in relation to ICU problems. Clin Intensive Care 4:183, 1993
20. Bahrami S, Schlag G, Yao YM, et al: Significance of translocation/endotoxin in the development of systemic sepsis following trauma and/or hemorrhage. Prog Clin Biol Res 392:197, 1995
21. Hu S, Sheng ZY, Tian HM: A clinically relevant model of multiple organ failure in the rabbit. Circ Shock 34:70, 1991
22. Yao YM, Tian HM, Sheng ZY, et al: The role of endotoxin in the pathogenesis of experimental multiple systemic organ failure: A preliminary report. Chin Med Sci J 7:161, 1992
23. Rietschel ET, Galanos C: Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis. Infect Immun 15:34, 1977
24. Obayashi T, Tamura H, Tanaka S, et al: Removal of limulus test-interfering factor in blood samples with perchloric acid and the improvement of the specificity of the limulus test by fractionating amebocyte lysate. Prog Clin Biol Res 231:357, 1987
25. Faist E, Mewes A, Strasser T, et al: Alteration of monocyte function following major injury. Arch Surg 123:287, 1988
26. 2 in immune suppression following injury. Ann Surg 214:253, 1991
27. Gadd MA, Hansbrough JF: Postburn suppression of murine lymphocyte and neutrophil functions is not reversed by prostaglandin blockade. J Surg Res 48:84, 1990
28. Waymack JP, Yurt R: The effect of prostaglandin E on immune function in multiple experimental model. Arch Surg 123:1429, 1988
29. Baud L, Perez J, Friedlaender G, et al: Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cells. FEBS Lett 239:50, 1988
30. 2. J Surg Res 48:523, 1990
31. Schlag G, Redl H, Dinges HP, et al: Bacterial translocation in a baboon model of hypovolemic-traumatic shock. In Schlag G, Redl H, Siegel JH, et al. (eds): Shock, Sepsis, and Organ Failure: Second Wiggers Bernard Conference. Berlin Heidelberg, Springer-Verlag, 1990, pp 53-83
32. Ayala A, Perrin MM, Meldrum DR, et al: Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 2:170, 1990
33. Hoch RC, Rodriguez R, Manning T, et al: Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 21:839, 1993
34. Endo S, Inada K, Yamada Y, et al: Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock. Crit Care Med 22:949, 1994
35. Ziegler EJ, McCutchan JA, Fierer J, et al: Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307:1225, 1982
36. Dunn DL: Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis. World J Surg 11:233, 1987
37. Quezado ZMN, Natanson C, Alling DW, et al: A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA 269:2221, 1993
38. Marra MN, Thornton MB, Snable JL, et al: Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5. Crit Care Med 22:559, 1994
39. Mayoral JL, Schweich CJ, Dunn DL: Decreased tumor necrosis factor production during the initial stages of infection correlates with survival during murine gram-negative sepsis. Arch Surg 125:24, 1990
40. Fang IS, Wisniewski MA, Huntenburg CC, et al: Inhibition of lipopolysaccharide-associated endotoxin activities in vitro and in vivo by the human anti-lipid A monoclonal antibody SdJ5-1.17.15. Infect Immun 61:3873, 1993
41. Yao YM, Tian HM, Sheng ZY, et al: Inhibitory effects of low-dose polymyxin B on hemorrhage-induced endotoxin/ bacterial translocation and cytokine formation in rats. J Trauma 38:924, 1995